126 related articles for article (PubMed ID: 18457265)
1. [Expression and mutation of myc antagonist genes Mad1, Mxi1 and Rox in leukemia cells].
Suo XH; Pan L; Yao L; Zhang XJ; Niu ZY; Dong ZR
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):745-9. PubMed ID: 18457265
[TBL] [Abstract][Full Text] [Related]
2. Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.
Guo XL; Pan L; Zhang XJ; Suo XH; Niu ZY; Zhang JY; Wang F; Dong ZR; Da W; Ohno R
Leuk Lymphoma; 2007 Jun; 48(6):1200-7. PubMed ID: 17577784
[TBL] [Abstract][Full Text] [Related]
3. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
Naderi S; Blomhoff HK
J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
[TBL] [Abstract][Full Text] [Related]
4. Expression and subcellular localization of the Myc superfamily proteins: c-Myc, Max, Mad1 and Mxi1 in the epiphyseal plate cartilage chondrocytes of growing rats.
Wang Y; Toury R; Hauchecorne M; Balmain N
Cell Mol Biol (Noisy-le-grand); 1997 Mar; 43(2):175-88. PubMed ID: 9130602
[TBL] [Abstract][Full Text] [Related]
5. Mad1 is a transcriptional repressor of Bcl-6.
Lee SC; Bottaro A; Chen L; Insel RA
Mol Immunol; 2006 May; 43(12):1965-71. PubMed ID: 16423395
[TBL] [Abstract][Full Text] [Related]
6. [Expressive profile of retinoblastoma-associated protein 46 and its clinical significance in acute leukemias].
Zhou JC; Zhang GS
Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):86-9. PubMed ID: 15921624
[TBL] [Abstract][Full Text] [Related]
7. [Construct Mxi1 mutation gene expression vector from leukemia cell line KG1].
Guo XL; Niu ZY; Zhang GL; Yin FL; Yang L; Ren JH; Dong ZR; Zhu P; Pan L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jul; 43(4):498-502. PubMed ID: 22997883
[TBL] [Abstract][Full Text] [Related]
8. Mad 1 inhibits cell growth and proliferation but does not promote differentiation or overall survival in human U-937 monoblasts.
Hultquist A; Cetinkaya C; Wu S; Castell A; Erlandsson A; Larsson LG
Mol Cancer Res; 2004 Aug; 2(8):464-76. PubMed ID: 15328373
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of Mxi1-SRalpha and Mxi1-SRbeta in Myc antagonism.
Dugast-Darzacq C; Grange T; Schreiber-Agus NB
FEBS J; 2007 Sep; 274(17):4643-53. PubMed ID: 17697116
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta enforces senescence in Myc-transformed hematopoietic tumor cells through induction of Mad1 and repression of Myc activity.
Wu S; Hultquist A; Hydbring P; Cetinkaya C; Oberg F; Larsson LG
Exp Cell Res; 2009 Nov; 315(18):3099-111. PubMed ID: 19766114
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the MXI1 gene in prostate cancer.
Eagle LR; Yin X; Brothman AR; Williams BJ; Atkin NB; Prochownik EV
Nat Genet; 1995 Mar; 9(3):249-55. PubMed ID: 7773287
[TBL] [Abstract][Full Text] [Related]
12. Expression of programmed cell death proteins in patients with chronic myeloid leukemia.
Strnad M; Brajuskovic G; Strelic N; Todoric-Zivanovic B; Stamatovic D; Tatomirovic Z; Magic Z
J BUON; 2008; 13(3):403-8. PubMed ID: 18979557
[TBL] [Abstract][Full Text] [Related]
13. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.
Delpuech O; Griffiths B; East P; Essafi A; Lam EW; Burgering B; Downward J; Schulze A
Mol Cell Biol; 2007 Jul; 27(13):4917-30. PubMed ID: 17452451
[TBL] [Abstract][Full Text] [Related]
14. HIF-1alpha induces MXI1 by alternate promoter usage in human neuroblastoma cells.
Löfstedt T; Fredlund E; Noguera R; Navarro S; Holmquist-Mengelbier L; Beckman S; Påhlman S; Axelson H
Exp Cell Res; 2009 Jul; 315(11):1924-36. PubMed ID: 19254710
[TBL] [Abstract][Full Text] [Related]
15. Mxi1 isoforms are expressed in hematological cell lines and normal bone marrow.
Kawamata N; Sugimoto KJ; Sakajiri S; Oshimi K; Koeffler HP
Int J Oncol; 2005 May; 26(5):1369-75. PubMed ID: 15809730
[TBL] [Abstract][Full Text] [Related]
16. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
[TBL] [Abstract][Full Text] [Related]
17. Commonly occurring loss and mutation of the MXI1 gene in prostate cancer.
Prochownik EV; Eagle Grove L; Deubler D; Zhu XL; Stephenson RA; Rohr LR; Yin X; Brothman AR
Genes Chromosomes Cancer; 1998 Aug; 22(4):295-304. PubMed ID: 9669667
[TBL] [Abstract][Full Text] [Related]
18. Mxi1 regulates cell proliferation through insulin-like growth factor binding protein-3.
Ko JY; Yoo KH; Lee HW; Park JH
Biochem Biophys Res Commun; 2011 Nov; 415(1):36-41. PubMed ID: 22008548
[TBL] [Abstract][Full Text] [Related]
19. Point mutations of the Mxil gene are rare in prostate cancers.
Kawamata N; Park D; Wilczynski S; Yokota J; Koeffler HP
Prostate; 1996 Sep; 29(3):191-3. PubMed ID: 8827088
[TBL] [Abstract][Full Text] [Related]
20. [Expression of pig7 in acute leukemia and its clinical significance].
Wang DH; Wang Y; Wang M; Liu H; Xu ZF; Rao Q; Meng JH; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):532-6. PubMed ID: 18078129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
